Roche seeking others to make Tamiflu bird flu drug

	Tweet

According to Swiss drug maker Roche, the maker of the sort-after bird flu drug Tamiflu, it is seeking for outside producers for its drug, because of the skyrocketing demand amid concerns about a possible bird flu pandemic.

Apparently Roche Chairman Franz Humer has said the company is currently assessing which organisations and countries have the ability to supplement their own capability.

He believes whether or not countries should stockpile the drug was up to individual nations.

Tamiflu, an antiviral drug approved for use as a treatment but not cure for seasonal flu, has been at the centre of escalating demand, amid mounting concerns of a potential flu pandemic that could be caused by the H5N1 strain of bird flu.

It seems countries, companies and individuals have been stockpiling the prescription drug, prompting Roche to suspend deliveries in the United States last week to prevent a run on stocks by consumers and companies.

The accelerated demand for the drug has forced Roche to say it will discuss with other companies, in the main makers of generic or copy cat drugs, and with governments in developing countries, as to whether they can help in the production of the drug.

Roche had previously said it would not let patents stand in the way of getting Tamiflu to patients in case of a bird flu pandemic.

However countries, such as Argentina and Taiwan, have jumped the gun and are saying they will produce their own version of Tamiflu.

RELATED STORIES:
Pharmaceutical and Biotechnology Industry in the ‘New’ EU Countries Presents Considerable Potential,   Strong Drugs without the Addiction   Onyx Shares Fall on Cancer Drug Filing   Keppra promising for newly diagnosed epilepsy   U.S. FDA nominee faces senators after Plan B move   WHO calls for urgent studies on best use of Tamiflu   Putting an old drug to a new use   Vaccine thwarts drug-resistant pneumonia, meningitis   Florida sues generic drug makers for overcharging   FDA grants fast track status for ViroPharma’s Maribavir   Half of Internet “Viagra” could be fake: study   Pfizer arthritis drug gets heart test

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]